Aileron Therapeutics Inc (NASDAQ:ALRN)
| 2.07 Delayed Data As of Dec 06 |  -0.365 / -14.81%Today’s Change | 1.01 Today|||52-Week Range 3.30 | -12.66% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 325.0K | 232.0K | 95.0K | 218.0K | ||
| Operating Expenses | Gross Income | -325.0K | -232.0K | -95.0K | -218.0K | |
| General Expenses | 12.6M | 17.9M | 22.9M | 31.7M | ||
| Research And Development | 7.8M | 10.3M | 14.2M | 18.4M | ||
| Total Operating Expenses | 12.9M | 18.2M | 23.0M | 31.9M | ||
| Non-Operating Expenses | Operating Income | -12.9M | -18.2M | -23.0M | -31.9M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.9M | -18.1M | -22.6M | -31.5M | |
| Preferred Dividend | -71.0K | -75.0K | -41.0K | 0.00 | ||
| Net Income | -12.9M | -18.1M | -22.6M | -31.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 14.7M | 14.7M | 7.4M | 14.7M | |
| Shares To Calculate EPS Diluted | 14.7M | 14.7M | 7.4M | 14.7M | ||
| Earnings Per Share | EPS | -$0.88 | -$1.91 | -$3.04 | -$2.14 | |
| EPS Diluted | -$0.88 | -$1.24 | -$3.04 | -$2.14 | ||
